Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (61)
  • 2024 (55)
  • 2023 (74)
  • 2022 (113)
  • 2021 (87)
  • 2020 (11)
  • 2019 (7)
  • 2018 (2)
  • 2017 (3)
  • 2003 (1)

Subject

  • Drug Trafficking (4124)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (371)
  • Overdose (325)
  • Major Law Enforcement Operation (275)
  • Diversion Division (253)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Money Laundering (210)
  • Gangs (200)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (30)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (227)
  • Outreach/Drug Prevention (187)
  • Terrorism (14)

Drug Name

  • Fentanyl (84)
  • Opioids (59)
  • Oxycodone (49)
  • Synthetic Opioids (27)
  • Methamphetamine (19)
  • Hydromorphone (15)
  • Cocaine (12)
  • Benzodiazepines (9)
  • Morphine (8)
  • Amphetamines (4)
  • Heroin (3)
  • Ketamine (3)
  • Marijuana (Cannabis) (3)
  • Methadone (3)
  • Steroids (3)
  • GHB (1)

Field Division

  • Washington, DC (59)
  • St. Louis (42)
  • Omaha (35)
  • Sede (34)
  • New York (30)
  • Miami (23)
  • El Paso (22)
  • Chicago (21)
  • Seattle (20)
  • Atlanta (14)
  • New Jersey (14)
  • Rocky Mountain (13)
  • New Orleans (12)
  • Dallas (10)
  • Houston (10)
  • Phoenix (10)
  • San Diego (10)
  • Los Angeles (9)
  • San Francisco (9)
  • New England (8)
  • Louisville (6)
  • Detroit (5)
  • Philadelphia (3)
Clear All Results
419 Results - Showing 1 to 10
PRESS RELEASE

DEA’s Fentanyl Free America Billboards Remind Omaha Community of Local Threat, Work to be Done

OMAHA, Neb. – Four billboards designed to spark conversation about fentanyl popped up Feb. 2, in eastern Omaha in support of the Drug Enforcement Administration’s (DEA) Fentanyl Free America initiative. Fentanyl Free America is DEA’s commitment to protecting the United States from synthetic opioids, such as fentanyl, by disrupting supply...
PRESS RELEASE

DEA and NFL Alumni Health Team Up on Football’s Biggest Stage to Tackle the Fentanyl Crisis

SAN FRANCISCO – For a third consecutive year, the U.S. Drug Enforcement Administration and NFL Alumni Health (NFLAH) are joining forces to raise awareness about the dangers of fentanyl and spreading a critical message: One Pill Can Kill . Building on the success of the last two year, this collaboration...
PRESS RELEASE

Former Anesthesiology Resident Who Worked at Seattle Children's, UW Medicine, and Harborview Medical Center, Sentenced for Stealing and Using Narcotic Pain Medicine While on Duty

SEATTLE – A 36-year-old former anesthesiology resident at Seattle Children’s Hospital and Harborview and University of Washington Medical Centers was sentenced today in U.S. District Court in Seattle to one year of supervised release including 200 hours of community service for diverting narcotic pain medication to his own use while...
PRESS RELEASE

El Paso Doctor Enters $200,000 Settlement Following State and Federal Fraud Allegations

EL PASO, Texas – Dr. Brian August, located in El Paso, has agreed to pay $200,000 to resolve allegations that he violated the Controlled Substances Act, the False Claims Act, and the Texas Health Care Program Fraud Prevention Act. The allegations involved the issuance of 255 controlled substance prescriptions to...
PRESS RELEASE

Portland Veterinarian Sentenced for Diverting Controlled Substances for Personal Use

PORTLAND, Ore. — Dr. Brenda Brown-Carlson, a Portland veterinarian, was sentenced to 60 months of supervised probation on January 13, 2026, in Multnomah County Circuit Court as part of a plea agreement. Brown-Carlson admitted to diverting controlled substances for her personal use and replacing them with saline, impacting the treatment...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

SAN FRANCISCO– The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Washington, DC – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

ARIZONA – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

DALLAS – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

OMAHA – The U.S. Drug Enforcement Administration (DEA) is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing the supply and demand for fentanyl. Through intensified enforcement operations and heightened intelligence...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster